Astera Labs, Inc. $ALAB Shares Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in Astera Labs, Inc. (NASDAQ:ALAB) by 31.6% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 854,492 shares of the company’s stock after buying an additional 205,301 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.49% of Astera Labs worth $412,737,000 at the end of the most recent reporting period.

A number of other institutional investors also recently added to or reduced their stakes in the business. Keating Financial Advisory Services Inc. bought a new position in Astera Labs in the 2nd quarter valued at about $25,000. Archer Investment Corp bought a new stake in Astera Labs during the second quarter worth approximately $30,000. Transamerica Financial Advisors LLC acquired a new stake in Astera Labs in the second quarter worth approximately $35,000. Johnson Financial Group Inc. bought a new position in Astera Labs during the 2nd quarter valued at $43,000. Finally, Bell Investment Advisors Inc acquired a new position in shares of Astera Labs during the 2nd quarter valued at $43,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

Insider Transactions at Astera Labs

In other Astera Labs news, Director Jack R. Lazar sold 10,000 shares of the stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $355.17, for a total value of $3,551,700.00. Following the completion of the sale, the director owned 75,688 shares in the company, valued at $26,882,106.96. This represents a 11.67% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 8,994 shares of the business’s stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $450.00, for a total transaction of $4,047,300.00. Following the transaction, the director owned 4,631 shares in the company, valued at approximately $2,083,950. This represents a 66.01% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 419,244 shares of company stock worth $163,135,169. 10.40% of the stock is owned by company insiders.

Analyst Ratings Changes

ALAB has been the subject of several research reports. Barclays raised their target price on Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a research note on Monday, July 20th. Evercore reissued an “outperform” rating and set a $297.00 target price on shares of Astera Labs in a research note on Tuesday, May 19th. Stifel Nicolaus lifted their price target on shares of Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a research report on Wednesday, June 24th. Jefferies Financial Group raised their price objective on Astera Labs from $270.00 to $450.00 and gave the stock a “buy” rating in a research note on Wednesday, August 5th. Finally, Roth Capital reaffirmed a “buy” rating and set a $450.00 target price on shares of Astera Labs in a report on Wednesday, August 5th. One analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have given a Hold rating to the company. According to MarketBeat, Astera Labs has a consensus rating of “Moderate Buy” and an average price target of $340.53.

Astera Labs Stock Performance

Shares of ALAB stock opened at $289.47 on Monday. The company has a market capitalization of $50.22 billion, a price-to-earnings ratio of 143.30 and a beta of 3.84. Astera Labs, Inc. has a 1-year low of $97.89 and a 1-year high of $499.48. The stock’s fifty day simple moving average is $342.38 and its 200-day simple moving average is $250.08.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. The firm had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The business’s quarterly revenue was up 104.5% compared to the same quarter last year. During the same period last year, the company posted $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, sell-side analysts predict that Astera Labs, Inc. will post 2.7 EPS for the current year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.